Weight loss patches are topical products applied to the skin that claim to deliver ingredients transdermally
For the treatment-regimen estimand, the mean body weight reductions from baseline at 72 weeks were 15.0%, 19.5%, and 20.9% in the tirzepatide 5, 10, and 15 mg groups, respectively, versus 3.1% in the placebo group
Read guide Patient feedback on GLP-1 clinician review, pharmacy sourcing, follow-up, and practical support
Pinch the tissue at your lower abdomen (two inches from the navel), the front of your mid-thigh, and the back of your upper arm
Clinical trial evidence from SURMOUNT-1 The landmark SURMOUNT-1 trial, published by Jastreboff and colleagues, provided some of the cleanest data on tirzepatide and hair loss